Literature DB >> 7966600

Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

H Okamoto1, F Tsuda, Y Akahane, Y Sugai, M Yoshiba, K Moriyama, T Tanaka, Y Miyakawa, M Mayumi.   

Abstract

Hepatitis B virus (HBV) DNA clones were propagated from 57 carriers with antibody to hepatitis B e antigen (HBeAg) and sequenced within nucleotides (nt) 1685 to 1926 including the core promoter (nt 1742 to 1849) and the pre-C region (nt 1814 to 1900). Mutations in the core promoter or those in the pre-C region, or both, were detected in 328 (97.9%) of 335 clones from them. Five carriers were infected with HBV mutants with mutations in the core promoter alone, while 20 carriers were infected only with those in the pre-C region to abort the translation of HBeAg precursor; the remaining 32 carriers were infected with HBV mutants with mutations in both the core promoter and pre-C region. Some carriers infected with HBV with mutations in the core promoter exclusively had high HBV DNA titers, comparable with those in carriers infected with wild-type HBV, thereby indicating that such mutations would not affect the transcription of the HBV pregenome extensively. Two point mutations in the core promoter, from A to T at nt 1762 and from G to A at nt 1764, were most prevalent. The other mutations included a point mutation at either of the two nucleotides and their deletion. All of these mutations involved the TTAAA sequence (nt 1758 to 1762) at 28 bp upstream of the initiation site for shorter pre-C mRNAs (nt 1790 +/- 1). The ATAAATT sequence (nt 1789 to 1795) at 23 bp upstream of the initiation site for the pregenome RNA (nt 1818), however, remained intact in all 335 HBV DNA clones. HBV mutants with mutations in the core promoter, unaccompanied by pre-C mutations, prevailed and replaced wild-type HBV in two carriers as they seroconverted from HBeAg to the corresponding antibody. These results indicate that HBV mutants with an HBeAg- phenotype would be generated by mutations in the core promoter which might abort the transcription of pre-C mRNA but do not seriously affect that of pregenome RNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966600      PMCID: PMC237274          DOI: 10.1128/JVI.68.12.8102-8110.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Expression of hepatitis B viral core region in mammalian cells.

Authors:  M J Roossinck; S Jameel; S H Loukin; A Siddiqui
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

3.  Fine structure genetic analysis of a beta-globin promoter.

Authors:  R M Myers; K Tilly; T Maniatis
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

4.  Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences.

Authors:  A McLachlan; D R Milich; A K Raney; M G Riggs; J L Hughes; J Sorge; F V Chisari
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  A T to A base substitution and small deletions in the conalbumin TATA box drastically decrease specific in vitro transcription.

Authors:  B Wasylyk; P Chambon
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

6.  Promoter sequences of eukaryotic protein-coding genes.

Authors:  J Corden; B Wasylyk; A Buchwalder; P Sassone-Corsi; C Kedinger; P Chambon
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

7.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Immunochemical structure of hepatitis B e antigen in the serum.

Authors:  K Takahashi; A Machida; G Funatsu; M Nomura; S Usuda; S Aoyagi; K Tachibana; H Miyamoto; M Imai; T Nakamura; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease.

Authors:  M Horikita; S Itoh; K Yamamoto; T Shibayama; F Tsuda; H Okamoto
Journal:  J Med Virol       Date:  1994-09       Impact factor: 2.327

View more
  101 in total

1.  Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression.

Authors:  S Barnabas; O M Andrisani
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Early mutation of precore (A1896) region prior to core promoter region mutation leads to decrease of HBV replication and remission of hepatic inflammation.

Authors:  Y Karino; J Toyota; T Sato; T Ohmura; K Yamazaki; T Suga; K Nakamura; M Sugawara; T Matsushima; K Hino
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 3.  Immune escape by hepatitis B viruses.

Authors:  U Protzer; H Schaller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

4.  Viral replication modulated by synthetic peptide derived from hepatitis B virus X protein.

Authors:  Chang-Zheng Song; Qing-Wei Wang; Chang-Cheng Song; Zeng-Liang Bai
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

5.  Current status of antiviral therapy for hepatitis B.

Authors:  Daryl T-Y Lau; Wissam Bleibel
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

6.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

7.  Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection.

Authors:  Jong-Han Lee; Kwang-Hyub Han; Jae Myun Lee; Jeon Han Park; Hyon-Suk Kim
Journal:  Clin Vaccine Immunol       Date:  2011-04-13

8.  A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA.

Authors:  A H Kidd; K Kidd-Ljunggren
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  Prevalence of mutations in core promoter/precore region in Japanese patients with chronic hepatitis B virus infection.

Authors:  A Nagasaka; S Hige; M Marutani; I Tsunematsu; M Saito; Y Yamamoto; S Konishi; M Asaka
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

10.  Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii.

Authors:  Mayumi Sakurai; Fuminaka Sugauchi; Naoky Tsai; Seiji Suzuki; Izumi Hasegawa; Kei Fujiwara; Etsuro Orito; Ryuzo Ueda; Masashi Mizokami
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.